KRA · Class II · 21 CFR 870.1210

FDA Product Code KRA: Catheter, Continuous Flush

FDA product code KRA covers continuous flush catheters used for hemodynamic pressure monitoring.

These catheters incorporate a slow continuous infusion mechanism that maintains line patency and prevents thrombus formation in arterial pressure monitoring lines and pulmonary artery catheters. They deliver a controlled flush rate of 3 mL/hour without requiring manual flushing.

KRA devices are Class II medical devices, regulated under 21 CFR 870.1210 and reviewed by the FDA Cardiovascular panel.

Leading manufacturers include Medos International SARL, Suzhou Zenith Vascular SciTech Limited and Invera Medical.

173
Total
173
Cleared
122d
Avg days
1977
Since
Declining activity - 2 submissions in the last 2 years vs 10 in the prior period
Review times increasing: avg 310d recently vs 120d historically

FDA 510(k) Cleared Catheter, Continuous Flush Devices (Product Code KRA)

173 devices
1–24 of 173

About Product Code KRA - Regulatory Context

510(k) Submission Activity

173 total 510(k) submissions under product code KRA since 1977, with 173 receiving FDA clearance (average review time: 122 days).

Submission volume has declined in recent years - 2 submissions in the last 24 months compared to 10 in the prior period.

FDA Review Time

Recent submissions under KRA have taken an average of 310 days to reach a decision - up from 120 days historically. Manufacturers should account for longer review timelines in current project planning.

KRA devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →